I am unclear about the potential for an interim an
Post# of 144694
On the severe trial they mentioned 50 patients with 2 week data.
With that said, I think its worth trying to get the FDA to take a peek sooner if possible. Im just tempering my expectations.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)